Real-World Data on Apatinib Efficacy - Results of a Retrospective Study in Metastatic Breast Cancer Patients Pretreated With Multiline Treatment
ObjectivesThe NCCN guidelines recommend that the addition of bevacizumab should be considered in metastatic breast cancers in some circumstances, but there are no recommendations for the similar antiangiogenic drug apatinib. The aim of this study was to evaluate the safety and efficacy of apatinib i...
Main Authors: | Zhaoyun Liu, Jing Shan, Qian Yu, Xinzhao Wang, Xiang Song, Fukai Wang, Chao Li, Zhiyong Yu, Jinming Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-06-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.643654/full |
Similar Items
-
The Efficacy And Safety Of Apatinib Treatment For Patients With Metastatic Or Recurrent Cervical Cancer: A Retrospective Study
by: Yu J, et al.
Published: (2019-09-01) -
Remarkable Response of Metastatic Gallbladder Carcinoma to Apatinib After Failed Multiline Chemotherapies: A Case Report and Literature Review
by: Mengxi Zhang, et al.
Published: (2019-11-01) -
Low-Dose Apatinib Combined With S-1 in Refractory Metastatic Colorectal Cancer: A Phase 2, Multicenter, Single-Arm, Prospective Study
by: Ning Li, et al.
Published: (2021-09-01) -
Phase II study of apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative metastatic breast cancer and clinical implications of monitoring ctDNA
by: Anjie Zhu, et al.
Published: (2021-08-01) -
Apatinib Treatment in Metastatic Gastrointestinal Stromal Tumor
by: Zhaolun Cai, et al.
Published: (2019-06-01)